J Korean Neurosurg Soc.  2019 Mar;62(2):201-208. 10.3340/jkns.2018.0144.

Efficacy and Safety of Endovascular Treatment in Patients with Internal Carotid Artery Occlusion and Collateral Middle Cerebral Artery Flow

Affiliations
  • 1Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea. yangha.hwang@gmail.com
  • 2Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea.
  • 3Cerebrovascular Center, Kyungpook National University Hospital, Daegu, Korea.
  • 4Department of Neurosurgery, School of Medicine, Kyungpook National University, Daegu, Korea.

Abstract


OBJECTIVE
In patients with internal carotid artery (ICA) occlusion, collateral middle cerebral artery (MCA) flow has a protective role against ischemia. However, some of these patients may experience initial major neurological deficits and major worsening on following days. Thus, we investigated the safety and efficacy of endovascular treatment (EVT) for ICA occlusion with collateral MCA flow by comparing clinical outcomes of medical treatment versus EVT.
METHODS
The inclusion criteria were as follows : 1) acute ischemic stroke with ICA occlusion and presence of collateral MCA flow on transfemoral cerebral angiography (TFCA) and 2) hospital arrival within 12 hours from symptom onset. The treatment strategy was made by the attending physician based on the patient's clinical status and results of TFCA.
RESULTS
Eighty-one patients were included (30 medical treatment, 51 EVT). The EVT group revealed a high incidence of intracranial ICA occlusion, longer ipsilesional MCA contrast filling time, and a similar rate of favorable clinical outcome despite a higher mean baseline the National Institutes of Health Stroke Scale (NIHSS) score. By binary logistic regression analysis, intravenous recombinant tissue plasminogen activator and EVT were independent predictors of favorable clinical outcome. In subgroup analysis based on stroke etiology, the non-atherosclerotic group showed a higher baseline NIHSS score, higher incidence of EVT, and a higher rate of distal embolization during EVT in comparison with the atherosclerotic group.
CONCLUSION
In patients with ICA occlusion and collateral MCA flow, decisions regarding treatment strategy based on TFCA can help achieve favorable clinical outcomes. EVT strategy with respect to etiology of ICA occlusion might help achieve better angiographic outcomes.

Keyword

Stroke; Internal carotid artery; Collateral circulation; Thrombectomy

MeSH Terms

Carotid Artery, Internal*
Cerebral Angiography
Collateral Circulation
Humans
Incidence
Ischemia
Logistic Models
Middle Cerebral Artery*
National Institutes of Health (U.S.)
Stroke
Thrombectomy
Tissue Plasminogen Activator
Tissue Plasminogen Activator

Cited by  1 articles

Impact of Collateral Circulation on Futile Endovascular Thrombectomy in Acute Anterior Circulation Ischemic Stroke
Yoo Sung Jeon, Hyun Jeong Kim, Hong Gee Roh, Taek-Jun Lee, Jeong Jin Park, Sang Bong Lee, Hyung Jin Lee, Jin Tae Kwak, Ji Sung Lee, Hee Jong Ki
J Korean Neurosurg Soc. 2024;67(1):31-41.    doi: 10.3340/jkns.2023.0139.


Reference

References

1. American Society of Interventional and Therapeutic Neuroradiology. Carotid artery balloon test occlusion. AJNR Am J Neuroradiol. 22(8 Suppl):S8–S9. 2001.
2. Barreto AD, Albright KC, Hallevi H, Grotta JC, Noser EA, Khaja AM, et al. Thrombus burden is associated with clinical outcome after intraarterial therapy for acute ischemic stroke. Stroke. 39:3231–3235. 2008.
Article
3. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 372:11–20. 2015.
4. Bisschops RH, Klijn CJ, Kappelle LJ, van Huffelen AC, van der Grond J. Collateral flow and ischemic brain lesions in patients with unilateral carotid artery occlusion. Neurology. 60:1435–1441. 2003.
Article
5. Bradac GB, Venturi F, Stura G, Coriasco M, Ventilii G, Garabello D, et al. Considerations about occlusion of the intracranial distal internal carotid artery. Clin Neuroradiol. 27:169–174. 2017.
Article
6. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 372:1009–1018. 2015.
Article
7. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 372:1019–1030. 2015.
Article
8. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 387:1723–1731. 2016.
Article
9. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet. 352:1245–1251. 1998.
Article
10. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 44:870–947. 2013.
Article
11. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 372:2296–2306. 2015.
Article
12. Kikuchi K, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Honda H. Balloon test occlusion of internal carotid artery: angiographic findings predictive of results. World J Radiol. 6:619–624. 2014.
Article
13. Kim JT, Park MS, Choi KH, Nam TS, Choi SM, Cho KH. Clinical implications of collateral middle cerebral artery flow in acute ischaemic stroke with internal carotid artery occlusion. Eur J Neurol. 18:1384–1390. 2011.
Article
14. Lee SU, Hong JM, Kim SY, Bang OY, Demchuk AM, Lee JS. Differentiating carotid terminus occlusions into two distinct populations based on Willisian collateral status. J Stroke. 18:179–186. 2016.
Article
15. Li W, Yin Q, Xu G, Liu X. Treatment strategies for acute ischemic stroke caused by carotid artery occlusion. Interv Neurol. 5:148–156. 2016.
Article
16. Liebeskind DS. Collateral circulation. Stroke. 34:2279–2284. 2003.
Article
17. Liebeskind DS, Cotsonis GA, Saver JL, Lynn MJ, Turan TN, Cloft HJ, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 69:963–974. 2011.
Article
18. Liebeskind DS, Flint AC, Budzik RF, Xiang B, Smith WS, Duckwiler GR, et al. Carotid I’s, L’s and T’s: collaterals shape the outcome of intracranial carotid occlusion in acute ischemic stroke. J NeuroInterv Surg. 7:402–407. 2015.
Article
19. Paciaroni M, Caso V, Venti M, Milia P, Kappelle LJ, Silvestrelli G, et al. Outcome in patients with stroke associated with internal carotid artery occlusion. Cerebrovasc Dis. 20:108–113. 2005.
Article
20. Sato K, Shimizu H, Inoue T, Fujimura M, Matsumoto Y, Kondo R, et al. Angiographic circulation time and cerebral blood flow during balloon test occlusion of the internal carotid artery. J Cereb Blood Flow Metab. 34:136–143. 2014.
Article
21. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 372:2285–2295. 2015.
Article
22. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, noninferiority trial. Lancet. 380:1241–1249. 2012.
Article
23. Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 44:2650–2663. 2013.
Article
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr